Variations in Practice Among Cirrhotic Patients With Portal Vein Thrombosis and Esophageal Varices: A North American Survey Study.
| Autor: | Mui BG; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Grinspan LT; Division of Liver Diseases and the Recanati/Miller Transplantation Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Crismale JF; Division of Liver Diseases and the Recanati/Miller Transplantation Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The American journal of gastroenterology [Am J Gastroenterol] 2024 Apr 01; Vol. 119 (4), pp. 774-777. Date of Electronic Publication: 2023 Dec 26. |
| DOI: | 10.14309/ajg.0000000000002640 |
| Abstrakt: | Introduction: There exists variation regarding the approach to anticoagulation and variceal hemorrhage (VH) prophylaxis among patients with cirrhosis and portal vein thrombosis (PVT). Methods: A survey was distributed to gastroenterology and hepatology providers to assess the approach to anticoagulation and VH prophylaxis among patients with PVT in cirrhotic patients. Results: Providers were more likely to start anticoagulation if the patient was listed for liver transplantation, was symptomatic, or had superior mesenteric vein thrombosis. For prevention of first VH, many providers opt for combination therapy with both nonselective beta blockers and variceal ligation. Discussion: Although providers agree on the clinical scenarios that merit initiation of anticoagulation, practice variation was identified in the means of preventing first VH. (Copyright © 2023 by The American College of Gastroenterology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|